PT649312E - Conjugados de antraciclina processo para a sua preparacao e sua utilizacao como agentes antitumor - Google Patents

Conjugados de antraciclina processo para a sua preparacao e sua utilizacao como agentes antitumor Download PDF

Info

Publication number
PT649312E
PT649312E PT94913560T PT94913560T PT649312E PT 649312 E PT649312 E PT 649312E PT 94913560 T PT94913560 T PT 94913560T PT 94913560 T PT94913560 T PT 94913560T PT 649312 E PT649312 E PT 649312E
Authority
PT
Portugal
Prior art keywords
anthracycline
gly
polymer
formula
mol
Prior art date
Application number
PT94913560T
Other languages
English (en)
Portuguese (pt)
Inventor
Francesco Angelucci
Antonino Suarato
Maria Grandi
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of PT649312E publication Critical patent/PT649312E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT94913560T 1993-05-11 1994-04-08 Conjugados de antraciclina processo para a sua preparacao e sua utilizacao como agentes antitumor PT649312E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939309663A GB9309663D0 (en) 1993-05-11 1993-05-11 Biologically active compounds

Publications (1)

Publication Number Publication Date
PT649312E true PT649312E (pt) 2002-01-30

Family

ID=10735264

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94913560T PT649312E (pt) 1993-05-11 1994-04-08 Conjugados de antraciclina processo para a sua preparacao e sua utilizacao como agentes antitumor

Country Status (25)

Country Link
US (1) US5571785A (cg-RX-API-DMAC7.html)
EP (1) EP0649312B1 (cg-RX-API-DMAC7.html)
JP (1) JPH08502519A (cg-RX-API-DMAC7.html)
KR (1) KR100330635B1 (cg-RX-API-DMAC7.html)
CN (1) CN1098106C (cg-RX-API-DMAC7.html)
AT (1) ATE203414T1 (cg-RX-API-DMAC7.html)
AU (1) AU671741B2 (cg-RX-API-DMAC7.html)
CA (1) CA2136438C (cg-RX-API-DMAC7.html)
DE (1) DE69427799T2 (cg-RX-API-DMAC7.html)
DK (1) DK0649312T3 (cg-RX-API-DMAC7.html)
ES (1) ES2161764T3 (cg-RX-API-DMAC7.html)
FI (1) FI112602B (cg-RX-API-DMAC7.html)
GB (1) GB9309663D0 (cg-RX-API-DMAC7.html)
GR (1) GR3036978T3 (cg-RX-API-DMAC7.html)
HU (2) HUT70509A (cg-RX-API-DMAC7.html)
IL (1) IL109528A (cg-RX-API-DMAC7.html)
MY (1) MY110974A (cg-RX-API-DMAC7.html)
NZ (1) NZ265266A (cg-RX-API-DMAC7.html)
PL (1) PL175325B1 (cg-RX-API-DMAC7.html)
PT (1) PT649312E (cg-RX-API-DMAC7.html)
RU (1) RU2145965C1 (cg-RX-API-DMAC7.html)
TW (1) TW268015B (cg-RX-API-DMAC7.html)
UA (1) UA42695C2 (cg-RX-API-DMAC7.html)
WO (1) WO1994026311A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA943212B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
GB9721070D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Bioactive derivatives of camptothecin
CA2445985A1 (en) * 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
US7049285B2 (en) * 2001-10-31 2006-05-23 Myung-Ok Park Biocompatible polymers including peptide spacer
US20050169883A1 (en) * 2002-05-06 2005-08-04 Prestwich Glenn D. Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
WO2005004805A2 (en) * 2003-07-02 2005-01-20 Solux Corporation Thermally stable crystalline epirubicin hydrochloride and method of making the same
IL325256A (en) 2014-06-13 2026-02-01 Bach Biosciences Llc FAP-activated medical materials and related uses
WO2015192124A1 (en) * 2014-06-13 2015-12-17 Trustees Of Tufts College Fap-activated therapeutic agents, and uses related thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
JPS60246400A (ja) * 1984-05-22 1985-12-06 Ajinomoto Co Inc アントラサイクリン系化合物及び制ガン剤
GB8614323D0 (en) * 1986-06-12 1986-07-16 Erba Farmitalia Anthracyclines
US5169937A (en) * 1986-11-18 1992-12-08 The Scripps Research Institute Method for producing stable glycosylated hemoglobin
DE3722699A1 (de) * 1987-07-09 1989-01-19 Behringwerke Ag Zytostatisch wirksame anthacyclin-konjugate
CA2014244A1 (en) * 1989-04-13 1990-10-13 Takeda Chemical Industries, Ltd. Stabilized composition of anthracyclines
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
GB9026491D0 (en) * 1990-12-05 1991-01-23 Erba Carlo Spa Anthracycline-conjugates

Also Published As

Publication number Publication date
RU2145965C1 (ru) 2000-02-27
HU9403811D0 (en) 1995-03-28
FI946128A7 (fi) 1994-12-28
CA2136438A1 (en) 1994-11-24
WO1994026311A1 (en) 1994-11-24
DE69427799T2 (de) 2002-05-02
JPH08502519A (ja) 1996-03-19
NZ265266A (en) 1996-06-25
EP0649312B1 (en) 2001-07-25
GR3036978T3 (en) 2002-01-31
PL306861A1 (en) 1995-04-18
CN1098106C (zh) 2003-01-08
KR950702201A (ko) 1995-06-19
CA2136438C (en) 2004-09-14
ATE203414T1 (de) 2001-08-15
AU671741B2 (en) 1996-09-05
IL109528A (en) 1998-08-16
IL109528A0 (en) 1994-08-26
UA42695C2 (uk) 2001-11-15
KR100330635B1 (ko) 2002-09-17
DE69427799D1 (de) 2001-08-30
AU6566694A (en) 1994-12-12
ZA943212B (en) 1995-01-18
PL175325B1 (pl) 1998-12-31
HU211538A9 (en) 1995-12-28
EP0649312A1 (en) 1995-04-26
DK0649312T3 (da) 2001-11-12
TW268015B (cg-RX-API-DMAC7.html) 1996-01-11
FI946128A0 (fi) 1994-12-28
FI112602B (fi) 2003-12-31
CN1108454A (zh) 1995-09-13
MY110974A (en) 1999-07-31
RU94046336A (ru) 1996-10-27
HUT70509A (en) 1995-10-30
ES2161764T3 (es) 2001-12-16
GB9309663D0 (en) 1993-06-23
US5571785A (en) 1996-11-05

Similar Documents

Publication Publication Date Title
AU749321B2 (en) Polymeric derivatives of camptothecins
US5773522A (en) Polymer-bound camptothecin derivatives
Greenwald et al. Camptothecin-20-PEG ester transport forms: the effect of spacer groups on antitumor activity
CA2437983C (en) Transporters comprising spaced arginine moieties
EP0038357A1 (en) Hydrolytic enzyme-activatible pro-drugs
HU9400800D0 (en) Polymer-bound paclitaxel derivatives process for producing them and pharmaceutical compositions containing them
JPH10513187A (ja) 高分子量のポリマーを基剤とするプロドラッグ
US12331016B2 (en) Multi-arm single molecular weight polyethylene glycol active derivative and application thereof
FI112602B (fi) Menetelmä biologisesti aktiivisten polymeerisitoutuneiden antrasykliinien valmistamiseksi
ES2353203T3 (es) Derivados de aloe-emodina y su uso en el tratamiento de patologias neoplasicas.
JP2001510486A (ja) カンプトテシンの生物活性誘導体
AU2002258050A1 (en) Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
US20050239688A1 (en) Method for the synthesis of anthracycline-peptide conjugates
ES2361921T3 (es) Inhibidores duales antitrombóticos que comprenden un residuo de biotina.
IE49782B1 (en) Bis(4-demethoxydaunorubicin)dihydrazone derivatives and pharmacologically acceptable salts thereof
CA3195573A1 (en) Crystalline form of aspacytarabine